mood shot of Swiss Lactoferrin powders with capsules and tablets
你的天然守護 乳鐵蛋白
乳鐵蛋白是一種天然存在於人體中的強效、多功能醣蛋白,特別集中於母乳、淚液和唾液中。它在身體的防禦系統中扮演關鍵角色,有助調節鐵質平衡、活化免疫反應,並維持腸道菌叢與炎症的穩定。
Preclinical and clinical studies have confirmed Lactoferrin's anti-inflammatory effects in dermal, respiratory, and gastrointestinal inflammation
Lactoferrin supports gut health, balances intestinal flora and probiotic
Lactoferrin supports IRON HEALTH, anemia
Lactoferrin can help improve immune system and its anti-inflammatory effects help to stable the health.
Lactoferrin supports bone health
  • 免疫力
  • 腸道
  • 鐵質
  • 肌膚
  • 骨骼
 

免疫腸道開始

約 70% 的免疫細胞集中在腸道。乳鐵蛋白能強化防禦力,同時調節過度反應,幫助免疫系統維持穩定平衡。

腸道好,健康自然好

Lactoferrin antivirus
Lactoferrin antibacterial
Lactoferrin Anti-inflammatory
Lactoferrin antivirus
How Lactoferrin Supports You as a protector

守護

How Lactoferrin Supports You as a defender.

防禦

How Lactoferrin Supports You as a supporter

支援

 
A capsule a day, Lactoferrin with you always.
Hand holding a small Lactovital's gut health tablet
Lactovital Lactoferrin kids immune booster helps kid growth development.
 
重要免責聲明
本頁面內容僅供一般教育及參考用途,旨在分享關於乳鐵蛋白(Lactoferrin)的科學研究及知識,並非用作診斷、治療、治癒或預防任何疾病之醫療建議。文中提及的科學研究多數為體外實驗、動物實驗或初步人體研究,結果未必適用於所有人,亦不代表最終臨床療效。乳鐵蛋白並非藥物,亦不可替代正規醫療診斷或治療。如您有任何健康問題,請務必諮詢註冊醫生或專業醫療人員。本網站不鼓勵自我診斷或自行用任何保健食品代替醫生處方。本頁內容不構成任何產品的宣傳、銷售建議或功效保證。產品實際效果因人而異。.

可摺疊的內容

Foot Note

[1] González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009). Lactoferrin: structure, function and applications. International journal of antimicrobial agents, 33(4), 301.e1–301.e3018.
[2] van der Strate, B. W., Beljaars, L., Molema, G., Harmsen, M. C., & Meijer, D. K. (2001). Antiviral activities of lactoferrin. Antiviral research, 52(3), 225–239.
[3] Rodríguez-Franco, D. A., Vázquez-Moreno, L., & Ramos-Clamont Montfort, G. (2005). Actividad antimicrobiana de la lactoferrina: mecanismos y aplicaciones clínicas potenciales [Antimicrobial mechanisms and potential clinical application of lactoferrin]. Revista latinoamericana de microbiologia, 47(3-4), 102–111.
[4] Czosnykowska-Łukacka, M., Orczyk-Pawiłowicz, M., Broers, B., & Królak-Olejnik, B. (2019). Lactoferrin in Human Milk of Prolonged Lactation. Nutrients, 11(10), 2350.
[5] Kell, D. B., Heyden, E. L., & Pretorius, E. (2020). The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Frontiers in immunology, 11, 1221.
[6] Fernandes, K. E., & Carter, D. A. (2017). The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens. Frontiers in microbiology, 8, 2.
[7] Legrand D. (2016). Overview of Lactoferrin as a Natural Immune Modulator. The Journal of pediatrics, 173 Suppl, S10–S15.
[8[ Actor, J. K., Hwang, S. A., & Kruzel, M. L. (2009). Lactoferrin as a natural immune modulator. Current pharmaceutical design, 15(17), 1956–1973.
[9[ Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008). Functions of natural killer cells. Nature immunology, 9(5), 503–510.
[10] Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008). Functions of natural killer cells. Nature immunology, 9(5), 503–510.
[11] González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009). Lactoferrin: structure, function and applications. International journal of antimicrobial agents, 33(4), 301.e1–301.e3018.
[12] Legrand D. (2016). Overview of Lactoferrin as a Natural Immune Modulator. The Journal of pediatrics, 173 Suppl, S10–S15.
[13] González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009). Lactoferrin: structure, function and applications. International journal of antimicrobial agents, 33(4), 301.e1–301.e3018.
[14] Kalmar, J. R., & Arnold, R. R. (1988). Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infection and immunity, 56(10), 2552–2557.
[15] Bortner, C. A., Arnold, R. R., & Miller, R. D. (1989). Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism. Canadian journal of microbiology, 35(11), 1048–1051.
[16] Valenti, P., & Antonini, G. (2005). Lactoferrin: an important host defence against microbial and viral attack. Cellular and molecular life sciences : CMLS, 62(22), 2576–2587.
[17] García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012). Lactoferrin a multiple bioactive protein: an overview. Biochimica et biophysica acta, 1820(3), 226–236.
[18] van der Strate, B. W., Beljaars, L., Molema, G., Harmsen, M. C., & Meijer, D. K. (2001). Antiviral activities of lactoferrin. Antiviral research, 52(3), 225–239.
[19] Qiu, J., Hendrixson, D. R., Baker, E. N., Murphy, T. F., St Geme, J. W., 3rd, & Plaut, A. G. (1998). Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proceedings of the National Academy of Sciences of the United States of America, 95(21), 12641–12646.
[20] Berkhout, B., Floris, R., Recio, I., & Visser, S. (2004). The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 17(3), 291–294.
[21] Chang, R., Ng, T. B., & Sun, W. Z. (2020). Lactoferrin as potential preventative and adjunct treatment for COVID-19. International journal of antimicrobial agents, 56(3), 106118.
[22] Hasegawa, K., Motsuchi, W., Tanaka, S., & Dosako, S. (1994). Inhibition with lactoferrin of in vitro infection with human herpes virus. Japanese journal of medical science & biology, 47(2), 73–85.
[23] Nozaki, A., Tanaka, K., Naganuma, A., & Kato, N. (2002). Nihon rinsho. Japanese journal of clinical medicine, 60(4), 819–829.
[24] Ikeda, M., Nozaki, A., Sugiyama, K., Tanaka, T., Naganuma, A., Tanaka, K., Sekihara, H., Shimotohno, K., Saito, M., & Kato, N. (2000). Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus research, 66(1), 51–63.
[25] Superti, F., Ammendolia, M. G., Valenti, P., & Seganti, L. (1997). Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Medical microbiology and immunology, 186(2-3), 83–91.
[26] Oda, H., Kolawole, A. O., Mirabelli, C., Wakabayashi, H., Tanaka, M., Yamauchi, K., Abe, F., & Wobus, C. E. (2021). Antiviral effects of bovine lactoferrin on human norovirus. Biochemistry and cell biology = Biochimie et biologie cellulaire, 99(1), 166–172.
[27] Legrand D, Elass E, Carpentier M, Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem Cell Biol. 2006 Jun;84(3):282-90.
[28] Legrand D. (2016). Overview of Lactoferrin as a Natural Immune Modulator. The Journal of pediatrics, 173 Suppl, S10–S15.
[29] Drago-Serrano, M. E., Campos-Rodríguez, R., Carrero, J. C., & de la Garza, M. (2017). Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections. International journal of molecular sciences, 18(3), 501.
[30[ Kruzel ML, Zimecki M, Actor JK. Lactoferrin in a Context of Inflammation-Induced Pathology. Front Immunol. 2017 Nov 6;8:1438.
[31] Conneely OM. Antiinflammatory activities of lactoferrin. J Am Coll Nutr. 2001 Oct;20(5 Suppl):389S-395S; discussion 396S-397S.
[32] Fernandes, K. E., & Carter, D. A. (2017). The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens. Frontiers in microbiology, 8, 2.
[33] Kirkpatrick CH, Green I, Rich RR, Schade AL. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis. 1971 Dec;124(6):539-44.
[34] Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol. 2007 May 15;178(10):6367-73.
[35] Wakabayashi H, Abe S, Okutomi T, Tansho S, Kawase K, Yamaguchi H. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol Immunol. 1996;40(11):821-5.
[36] Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K., & Swart, P. J. (1999). Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrobial agents and chemotherapy, 43(11), 2635–2641.
[37] Cutone, A., Rosa, L., Ianiro, G., Lepanto, M. S., Bonaccorsi di Patti, M. C., Valenti, P., & Musci, G. (2020). Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules, 10(3), 456.
[38] Azhar J., Hussain T. & Mohammadabadi T. (2021). The overview on anti-cancer effects of milk lactoferrin. World J Pharm Sci, 9(5): 135-144.
[39] Cutone, A., Rosa, L., Ianiro, G., Lepanto, M. S., Bonaccorsi di Patti, M. C., Valenti, P., & Musci, G. (2020). Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules, 10(3), 456.
[40] Varadhachary A, Wolf JS, Petrak K, O'Malley BW Jr, Spadaro M, Curcio C, Forni G, Pericle F. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer. 2004 Sep 1;111(3):398-403.
[41] Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem. 1999 Sep 1;74(3):486-98.
[42] Ramírez-Rico G, Drago-Serrano ME, León-Sicairos N and de la Garza M (2022) Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer. Front. Pharmacol. 13:855852.
[43] Moradian, Fatemeh & Farziyan, Mohammad & Rafiei, Alireza. (2016). Anticancer Effect of Bovine Lactoferrin on Human Esophagus Cancer Cell Line. Res Mol Med. 4.
[44] Yu-Tang Tung, Hsiao-Ling Chen, Chih-Ching Yen, Po-Ying Lee, Hsin-Chung Tsai, Ming-Fong Lin, Chuan-Mu Chen, Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor, Journal of Dairy Science, Volume 96, Issue 4, 2013, Pages 2095-2106.
[45] Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies. Biochem Cell Biol. 2002;80(1):131-6.
[46] Gibbons JA, Kanwar RK, Kanwar JR. Lactoferrin and cancer in different cancer models. Front Biosci (Schol Ed). 2011 Jun 1;3(3):1080-8. doi: 10.2741/212.
[47] Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem. 1999 Sep 1;74(3):486-98.
[48[ Ramírez-Rico G, Drago-Serrano ME, León-Sicairos N and de la Garza M (2022) Lactoferrin: A Nutraceutical with Activity against Colorectal Cancer. Front. Pharmacol. 13:855852.
[49] Moradian, Fatemeh & Farziyan, Mohammad & Rafiei, Alireza. (2016). Anticancer Effect of Bovine Lactoferrin on Human Esophagus Cancer Cell Line. Res Mol Med. 4.
[50] Yu-Tang Tung, Hsiao-Ling Chen, Chih-Ching Yen, Po-Ying Lee, Hsin-Chung Tsai, Ming-Fong Lin, Chuan-Mu Chen, Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor, Journal of Dairy Science, Volume 96, Issue 4, 2013, Pages 2095-2106.
[51] Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies. Biochem Cell Biol. 2002;80(1):131-6.
[52] Gibbons JA, Kanwar RK, Kanwar JR. Lactoferrin and cancer in different cancer models. Front Biosci (Schol Ed). 2011 Jun 1;3(3):1080-8. doi: 10.2741/212.